ID 54075
Sort Key
4
Title Alternative
Current state of and views regarding clinical approarches to Helicobacter pylori infection
FullText URL
Thumnail 128_13.pdf 3.87 MB
Author
Keywords
Helicobacter pylori
除菌療法
胃癌
胃炎
MALT リンパ腫
Note
総説(Reviews)
Publication Title
岡山医学会雑誌
Published Date
2016-04-01
Volume
volume128
Issue
issue1
Publisher
岡山医学会
Publisher Alternative
Okayama Medical Association
Start Page
13
End Page
19
ISSN
0030-1558
NCID
AN00032489
Content Type
Journal Article
Related Url
isVersionOf https://doi.org/10.4044/joma.128.13
OAI-PMH Set
岡山大学
language
日本語
Copyright Holders
Copyright (c) 2016 岡山医学会
File Version
publisher
Refereed
True
DOI
NAID
Eprints Journal Name
joma
References
1) Sasaki M, Ogasawara N, Utsumi K, Kawamura N, Kamiya T, Kataoka H, Tanida S, Mizoshita T, Kasugai K, Joh T : Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin. J Clin Biochem Nutr (2010) 47, 53-58.
2) Miyoshi M, Mizuno M, Ishiki K, Nagahara Y, Maga T, Torigoe T, Nasu J, Okada H, Yokota K, Oguma K, Tsuji T : A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism. J Gastroenterol Hepatol (2001) 16, 723-728.
3) Inoue M, Okada H, Hori S, Kawahara Y, Kawano S, Takenaka R, Toyokawa T, Onishi Y, Shiratori Y, Yamamoto K : Does pretreatment with lansoprazole influence Helicobacter pylori eradication rate and quality of life? Digestion (2010) 81, 218-222.
4) Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ : Helicobacter pylori infection and the development of gastric cancer. N Engl J Med (2001) 345, 784-789.
5) Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K : Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter (2011) 16, 415-419.
6) Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T, Azuma T, Okazaki IM, Honjo T, Chiba T : Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med (2007) 13, 470-476.
7) Takeda Y, Yashima K, Hayashi A, Sasaki S, Kawaguchi K, Harada K, Murawaki Y, Ito H : Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. World J Gastrointest Oncol (2012) 4, 131-137.
8) Toyokawa T, Suwaki K, Miyake Y, Nakatsu M, Ando M : Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population : a long-term prospective cohort study. J Gastroenterol Hepatol (2010) 25, 544-547.
9) Kodama M, Murakami K, Okimoto T, Sato R, Uchida M, Abe T, Shiota S, Nakagawa Y, Mizukami K, Fujioka T : Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol (2012) 47, 394-403.
10) Takenaka R, Okada H, Kato J, Makidono C, Hori S, Kawahara Y, Miyoshi M, Yumoto E, Imagawa A, Toyokawa T, Sakaguchi K, Shiratori Y : Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther (2007) 25, 805-812.
11) Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K, Okada H, Shiratori Y : The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol (2005) 100, 1037-1042.
12) Ogura K, Hirata Y, Yanai A, Shibata W, Ohmae T, Mitsuno Y, Maeda S, Watabe H, Yamaji Y, Okamoto M, Yoshida H, Kawabe T, et al. : The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer. J Clin Gastroenterol (2008) 42, 79-83.
13) Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M ; Japan Gast Study Group : Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer : an open-label, randomised controlled trial. Lancet (2008) 372, 392-397.
14) Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, Liu WD, Hu Y, Han ZX, Crystal-Mansour S, Pee D, Blot WJ, et al. : Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst (2012) 104, 488-492.
15) Li WQ, Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, Liu WD, Hu Y, Han ZX, Crystal-Mansour S, Pee D, et al. : Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst (2014) 106.
16) Kamada T, Hata J, Sugiu K, Kusunoki H, Ito M, Tanaka S, Inoue K, Kawamura Y, Chayama K, Haruma K : Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori : results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther (2005) 21, 1121-1126.
17) Take S, Mizuno M, Ishiki K, Yoshida T, Ohara N, Yokota K, Oguma K, Okada H, Yamamoto K : The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol (2011) 46, 318-324.
18) Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K : Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J Gastroenterol (2007) 42, S21-27.
19) Labenz J, Blum AL, Bayerdörffer E, Meining A, Stolte M, Börsch G : Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology (1997) 112, 1442-1447.
20) Yagi S, Okada H, Takenaka R, Miyoshi M, Suzuki S, Toyokawa T, Kawahara Y, Yamamoto K : Influence of Helicobacter pylori eradication on reflux esophagitis in Japanese patients. Dis Esophagus (2009) 22, 361-367.
21) Bai Y, Wang Z, Bai X, Yu Z, Cao L, Zhang W, Ruan C : Cross-reaction of antibody against Helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura. Int J Hematol (2009) 89, 142-149.
22) Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M, Tari A, Kitadai Y, Matsumoto H, Nagaya T, Kamoshida T, Watanabe N ; JAPAN GAST Study Group : Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori : a multicentre cohort follow-up study of 420 patients in Japan. Gut (2012) 61, 507-513.
23) Takenaka R, Yokota K, Mizuno M, Okada H, Toyokawa T, Yamasaki R, Yoshino T, Sugiyama T, Asaka M, Shiratori Y, Oguma K : Serum antibodies to Helicobacter pylori and its heat-shock protein 60 correlate with the response of gastric mucosa-associated lymphoid tissue lymphoma to eradication of H. pylori. Helicobacter (2004) 9, 194-200.
24) Kawahara Y, Mizuno M, Yoshino T, Yokota K, Oguma K, Okada H, Fujiki S, Shiratori Y : HLA-DQA1*0103-DQB1 *0601 haplotype and Helicobacter pylori-positive gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol (2005) 3, 865-868.
25) Okada H, Takemoto M, Kawahara Y, Nasu J, Takenaka R, Kawano S, Inoue M, Ichimura K, Tanaka T, Shinagawa K, Yoshino T, Yamamoto K : A prospective analysis of efficacy and long-term outcome of radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma. Digestion (2012) 86, 179-186.
26) Kuo SH, Yeh KH, Wu MS, Lin CW, Hsu PN, Wang HP, Chen LT, Cheng AL : Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas. Blood (2012) 119, 4838-4844.
27) Akamatsu T, Ichikawa S, Okudaira S, Yokosawa S, Iwaya Y, Suga T, Ota H, Tanaka E : Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening. J Gastroenterol (2011) 46, 1353-1360.